Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1626 1772
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17928075 | SMALL MOLECULE INHIBITORS OF GRK5 AND GRK5 SUBFAMILY MEMBERS AND USES THEREOF | Non-Final OA | Purdue Research Foundation |
| 17434672 | COMPOUNDS FOR TARGETED THERAPIES OF CASTRATION RESISTANT PROSTATE CANCER | Non-Final OA | Purdue Research Foundation |
| 18548423 | ANTI-FIBROTIC THERAPIES | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18548356 | (METH)ACRYLATES CONTAINING A 4-THIAZOLIDINONE UNIT AND POLYMERS THEREOF | Non-Final OA | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN |
| 18548366 | MONOMERS CONTAINING A 4-THIAZOLIDINONE UNIT AND THEIR POLYAMIDE, POLYESTER AND POLYURETHANE POLYCONDENSATES | Non-Final OA | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN |
| 18022677 | METHODS AND MATERIALS FOR INCREASING NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE ACTIVITY | Final Rejection | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18548348 | BENZOXAZOLONE INHIBITORS OF INFLAMMASOMES | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18578744 | METHODS OF TREATING NEPHROTIC SYNDROME | Non-Final OA | The Research Institute at Nationwide Children's Hospital |
| 18559682 | Polymorph Of Imidazolidinone Compound, Preparation Method Therefor And Use Thereof | Non-Final OA | Betta Pharmaceuticals Co., Ltd. |
| 18282254 | PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | ZHEJIANG GENFLEET THERAPEUTICS CO., LTD. |
| 18564291 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | Non-Final OA | Schrödinger, Inc. |
| 18552784 | PREPARATION METHOD FOR BICYCLIC COMPOUND AND APPLICATION AS ANTIFUNGAL AGENT | Non-Final OA | JIANGXI JEMINCARE GROUP CO., LTD |
| 18548119 | NOVEL PROCESS FOR THE PREPARATION OF 2,5-DICHLORO-3-(5-(3,4-DIHYDROXY-5-NITROPHENYL)-1,2,4-OXADIAZOL-3-YL)-4,6-DIMETHYLPYRIDINE-1-OXIDE | Non-Final OA | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER |
| 18258418 | KCNT1 INHIBITORS AND METHODS OF USE | Final Rejection | Praxis Precision Medicines, Inc. |
| 18262712 | TRIAZINE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | Athos Therapeutics, Inc. |
| 18271924 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS | Final Rejection | Chengdu Anticancer Bioscience LTD |
| 18252024 | METHODS FOR DISRUPTING MITOCHONDRIAL UNFOLDED PROTEIN RESPONSE | Non-Final OA | Health Research, Inc. |
| 18023270 | COMPOUNDS AND METHODS OF USE | Non-Final OA | Ferro Therapeutics, Inc |
| 18006830 | CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS | Final Rejection | INSTITUT NATIONAL DES SCIENCES APPLIQUÉES DE ROUEN |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy